Connext Completes Enrollment in Phase 2 Trial of CNT201 in Dupuytren's Contracture – All 56 planned participants enrolled approximately five months after first patient… CISION PRNewswireAugust 17, 2026
Press ReleaseGROWNSY Launches "Ask a Pediatrician: Baby Congestion" Educational Content with Dr. Molly O'Shea NEW YORK, Aug. 17, 2026 /PRNewswire/ — GROWNSY, a baby care brand… CISION PRNewswireAugust 17, 2026
Press ReleaseUniphore Launches Marketing AI to Usher in New Era: NYSE Content Update NYSE issues a pre-market daily advisory direct from the trading floor. NEW… CISION PRNewswireAugust 17, 2026
Press ReleaseBitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 5.82 Million Tokens, and Total Crypto and Total Cash Holdings of $11.4 Billion Bitmine owns 4.8% of the total ETH coin supply of 120.7 million… CISION PRNewswireAugust 17, 2026
Press ReleaseGEEKOM Pushes the Boundaries of Mini PC Innovation with Four-Node A9 Mega AI Cluster The cluster runs DeepSeek V4 Flash locally, bringing private and scalable AI… CISION PRNewswireAugust 17, 2026
Insilico Medicine Included in MSCI Global Small Cap Indexes, Gaining Capital Market Endorsement in Core Strengths CAMBRIDGE, Mass., Aug. 17, 2026 /PRNewswire/ — Insilico Medicine ("Insilico", HKEX: 3696),… CISION PRNewswireAugust 17, 2026
OncoC4 Announces First Patient Dosing in Phase 1 Clinical Trial of ONC-783 for the Treatment of Advanced Solid Tumors — ONC-783 is the first-and-only clinical-stage T-cell engager targeting a cancer-specific glycoform… CISION PRNewswireAugust 17, 2026
Press ReleaseKelun-Biotech Announces 2026 Interim Results CHENGDU, China, Aug. 17, 2026 /PRNewswire/ — Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech"… CISION PRNewswireAugust 17, 2026
